Home  |  About JAPTR |  Editorial board  |  Search |  Ahead of print  |  Current issue  |  Archives |  Submit article  |  Instructions  |  Subscribe  |  Advertise  |  Contacts  |Login 
Users Online: 288   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
     

    Article Cited by others

ORIGINAL ARTICLE

Development of novel risperidone implants using blends of polycaprolactones and in vitro in vivo correlation studies

Navitha Aerrolla, Jogala Satheesh, Krishnamohan Chinnala, Aukunuru Jithan

Year : 2014| Volume: 5| Issue : 2 | Page no: 84-89

   This article has been cited by
 
1 Development of a dissolution method based on lipase for preclinical level A IVIVC of oral poly(e-caprolactone) microspheres
Paola A. Cárdenas,Álvaro Jiménez – Kairuz,Bibiana Verlindo de Araujo,Diana Marcela Aragon
Journal of Drug Delivery Science and Technology. 2019;
[Pubmed]  [Google Scholar] [DOI]
2 Pharmaceutical implants: classification, limitations and therapeutic applications
Zahra Mohtashami,Zahra Esmaili,Molood Alsadat Vakilinezhad,Ehsan Seyedjafari,Hamid Akbari Javar
Pharmaceutical Development and Technology. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
3 Recent Perspectives in Hot Melt Extrusion-Based Polymeric Formulations for Drug Delivery: Applications and Innovations
Yangmei Ren,Lan Mei,Liangxue Zhou,Gang Guo
AAPS PharmSciTech. 2019; 20(3)
[Pubmed]  [Google Scholar] [DOI]
4 Development of a dual extrusion printing technique for an acid- and thermo-labile drug
Wiebke Kempin,Vanessa Domsta,Iris Brecht,Beatrice Semmling,Susan Tillmann,Werner Weitschies,Anne Seidlitz
European Journal of Pharmaceutical Sciences. 2018;
[Pubmed]  [Google Scholar] [DOI]
5 Formulation of delivery systems with risperidone based on biodegradable terpolymers
Artur Turek,Aleksandra Borecka,Henryk Janeczek,Michal Sobota,Janusz Kasperczyk
International Journal of Pharmaceutics. 2018; 548(1): 159
[Pubmed]  [Google Scholar] [DOI]
6 Nanocrystal-based drug delivery system of risperidone: lyophilization and characterization
Dharmesh Gol,Shreya Thakkar,Manju Misra
Drug Development and Industrial Pharmacy. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
7 Pharmacokinetics and Safety of Risperidone Subcutaneous Implants in Stable Patients With Schizophrenia
Ryan Dammerman,Sonnie Kim,Mathews Adera,Alex Schwarz
Clinical Pharmacology in Drug Development. 2018;
[Pubmed]  [Google Scholar] [DOI]
8 Psychotropic implant can be a new hope in psychiatry
Guru S. Gowda,Soumitra Das,Raveesh Bevinahalli Nanjegowda
Asian Journal of Psychiatry. 2017;
[Pubmed]  [Google Scholar] [DOI]
9 Assessment of different polymers and drug loads for fused deposition modeling of drug loaded implants
Wiebke Kempin,Christian Franz,Lynn-Christine Koster,Felix Schneider,Malte Bogdahn,Werner Weitschies,Anne Seidlitz
European Journal of Pharmaceutics and Biopharmaceutics. 2017; 115: 84
[Pubmed]  [Google Scholar] [DOI]
10 Phase I, open-label, randomized, parallel study to evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM at different dose strengths in patients with schizophrenia or schizoaffective disorder (PRISMA-1)
Jordi Llaudó,Lourdes Anta,Ignacio Ayani,Javier Martínez,Juan Schronen,Margarita Morozova,Mikhail Ivanov,Ibón Gutierro
International Clinical Psychopharmacology. 2016; 31(6): 323
[Pubmed]  [Google Scholar] [DOI]
11 Electroconductive smart polyacrylamide–polypyrrole (PAC–PPY) hydrogel: a device for controlled release of risperidone
Suparna Saha,Priyabrata Sarkar,Mrinmoy Sarkar,Biplab Giri
RSC Adv.. 2015; 5(35): 27665
[Pubmed]  [Google Scholar] [DOI]

 

Read this article